Skip to content
HowShorted

How shorted is Enveric Biosciences, Inc.? ENVB

#3,428most shorted US stockof 3,805 ranked stocks, more shorted than 9%

0.51%
of shares outstanding reported short · settlement date 15 Sep 2026
vs previous report
+0.22
5 reports (~10 weeks)
−3.24
days to cover
1.00
Aggregate net short position time series for Enveric Biosciences, Inc.

Markers along the chart's base: ▲ results announced (an 8-K reporting results was filed) ▲ quarterly or annual report filed. Dates are SEC filing dates; hover a point to see events since the previous settlement.

Days to cover

FINRA's own figure: reported shares short divided by the stock's average daily trading volume, published alongside each settlement. It expresses the short position in days of typical trading rather than as a percentage of the company; the two can move differently.

Aggregate net short position time series for Enveric Biosciences, Inc. days to cover

Short interest around results

For each results announcement (an 8-K reporting results, by its SEC filing date), the FINRA settlement before it and the first one after. Settlements fall twice a month, so the two figures can sit up to a month apart and much else changes in between: this shows what was reported, not why.

Reported short interest before and after each results announcement
Results filedSettlement beforeSettlement afterChange
14 Aug 202510.32% 31 Jul 20257.16% 15 Aug 2025−3.16
14 May 20256.96% 30 Apr 20255.06% 15 May 2025−1.90
14 Nov 20243.70% 31 Oct 20242.74% 15 Nov 2024−0.96
12 Aug 20241.81% 15 Jul 20245.26% 15 Aug 2024+3.45
13 Nov 20230.90% 31 Oct 20230.31% 15 Nov 2023−0.59
14 Aug 20231.98% 31 Jul 20233.57% 15 Aug 2023+1.59
3 Apr 20230.77% 31 Mar 20231.08% 14 Apr 2023+0.31
1 Apr 20223.02% 31 Mar 20222.43% 14 Apr 2022−0.59

Fails to deliver

The SEC's fails-to-deliver figure for ENVB: the aggregate net balance of shares that failed to be delivered at each settlement date, published by the SEC twice a month and shown here verbatim for the trailing window. A balance is not a daily flow, and a fail has many ordinary causes; the SEC says it cannot guarantee the accuracy of the data. See what fails to deliver are and the largest balances today.

Last balance on file
1,427
10 Sep 2026
Highest in window
1,175,942
21 Apr 2026
Days with a balance
123
Window
16 Sep 2025 to 14 Sep 2026
Aggregate net short position time series for Enveric Biosciences, Inc. fails to deliver

Source: U.S. Securities and Exchange Commission, fails-to-deliver data (public domain). Only settlement days with a positive balance appear; the largest balance in the window was 1.2M shares.

Embed this chart

Paste this snippet to embed the interactive chart. It updates with each FINRA report and keeps the source attribution. Preview

Download chart cardShare on XRedditLinkedIn
Cite this page
Plain
Wikipedia
BibTeX

Sector: Healthcare

History

Full reported short interest history
Settlement dateShort %Change
15 Sep 20260.51%+0.22
31 Aug 20260.29%−0.10
14 Aug 20260.39%−2.76
15 May 20263.15%−0.19
15 Apr 20263.34%−0.41
31 Mar 20263.75%−2.43
15 Oct 20256.18%−3.33
30 Sep 20259.51%−2.13
15 Sep 202511.64%−0.61
29 Aug 202512.25%+5.09
15 Aug 20257.16%−3.16
31 Jul 202510.32%+1.68
15 Jul 20258.64%−2.24
30 Jun 202510.88%+1.64
13 Jun 20259.24%−3.08
30 May 202512.32%+7.26
15 May 20255.06%−1.90
30 Apr 20256.96%−0.09
15 Apr 20257.05%−0.21
31 Mar 20257.26%+6.58
31 Dec 20240.68%−0.90
13 Dec 20241.58%+0.42
29 Nov 20241.16%−1.58
15 Nov 20242.74%−0.96
31 Oct 20243.70%+1.53
15 Oct 20242.17%−0.06
30 Sep 20242.23%−0.06
13 Sep 20242.29%−1.43
30 Aug 20243.72%−1.54
15 Aug 20245.26%+3.45
15 Jul 20241.81%−0.27
28 Jun 20242.08%−1.61
14 Jun 20243.69%−0.95
31 May 20244.64%+1.15
28 Mar 20243.49%+3.35
30 Nov 20230.14%−0.17
15 Nov 20230.31%−0.59
31 Oct 20230.90%−0.22
13 Oct 20231.12%+0.61
29 Sep 20230.51%−0.62
15 Sep 20231.13%−0.93
31 Aug 20232.06%−1.51
15 Aug 20233.57%+1.59
31 Jul 20231.98%+0.97
14 Jul 20231.01%−0.77
30 Jun 20231.78%+0.69
15 May 20231.09%−0.47
28 Apr 20231.56%+0.48
14 Apr 20231.08%+0.31
31 Mar 20230.77%+0.30
15 Mar 20230.47%+0.20
28 Feb 20230.27%−0.17
15 Feb 20230.44%−0.27
31 Jan 20230.71%−0.82
13 Jan 20231.53%−0.42
30 Dec 20221.95%−0.24
15 Dec 20222.19%+0.47
30 Nov 20221.72%−0.37
15 Nov 20222.09%−2.33
31 Oct 20224.42%+1.17
14 Oct 20223.25%−2.01
15 Sep 20225.26%+0.55
31 Aug 20224.71%−1.30
15 Aug 20226.01%+1.52
30 Jun 20224.49%−1.39
15 Jun 20225.88%−0.28
31 May 20226.16%−0.15
13 May 20226.31%+3.88
14 Apr 20222.43%−0.59
31 Mar 20223.02%−3.13
15 Mar 20226.15%+2.98
15 Feb 20223.17%+1.32
14 Jan 20221.85%+1.09
31 Dec 20210.76%−0.55
15 Dec 20211.31%−1.35
30 Nov 20212.66%−2.19
15 Nov 20214.85%−4.28
29 Oct 20219.13%+1.22
15 Oct 20217.91%+1.97
30 Sep 20215.94%+2.10
31 Aug 20213.84%−0.20
13 Aug 20214.04%−0.88
30 Jul 20214.92%+0.37
15 Jul 20214.55%+0.67
30 Jun 20213.88%+1.06
15 Jun 20212.82%+0.90
14 May 20211.92%−0.84
30 Apr 20212.76%−1.93
15 Apr 20214.69%+4.27
15 Dec 20200.42%−0.25
30 Nov 20200.67%−0.97
13 Nov 20201.64%+0.37
30 Oct 20201.27%+0.45
15 Oct 20200.82%−0.87
14 Aug 20201.69%−1.62
31 Jul 20203.31%+0.84
15 Jul 20202.47%–

Newest first. Scroll inside the table for earlier dates, back to 15 Jul 2020.

Frequently asked questions

How shorted is Enveric Biosciences, Inc. right now?
0.51% of Enveric Biosciences, Inc.'s (ENVB) shares outstanding were reported short for settlement date 15 Sep 2026, per FINRA's consolidated short interest report. That makes it the 3,428th most shorted US stock, out of 3,805 we rank.
What does this number include?
FINRA member firms must report their short positions in all US equities twice a month; FINRA consolidates them per security. We divide that official share count by the company's shares outstanding from its SEC filings. This is the regulatory figure, not a daily estimate.
Why does it only update twice a month?
US short interest is reported for settlement on the 15th and the last business day of each month, and FINRA publishes the consolidated figures about nine business days later. That cadence is set by regulation; no daily official figure exists.
Is this ENVB's short float?
No. This is short interest as a percentage of shares outstanding, the count in the company's SEC filings. "Short float" divides the same FINRA short count by the public float, which excludes closely held shares, so it comes out higher for the same company. We publish no float estimates: the float is not a regulatory figure.
What is ENVB's days to cover?
1.00 days for settlement date 15 Sep 2026: FINRA's own short interest ratio, the reported shares short divided by average daily trading volume. It is published in the same FINRA file and shown verbatim; we hold no volume data ourselves.
Which funds are short?
US public short interest is aggregate-only: individual short sellers are not named. Only some EU markets publish named positions.